Related Experiment Video
Updated: Aug 16, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Juvenile dermatomyositis. Pathophysiology and disease expression
1Department of Pediatrics, Northwestern University Medical School, Illinois, USA.
Insights
Children with juvenile dermatomyositis (JDMS) symptoms like rash, muscle weakness, or fatigue need prompt medical attention. Advances in therapy can improve outcomes, and research is ongoing to understand JDMS disease factors.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Genetics
Background:
- Juvenile dermatomyositis (JDMS) and polymyositis (PM) are idiopathic inflammatory myopathies affecting children and adults.
- While sharing some clinical features, their distinct pathophysiologies are not fully elucidated.
- Early diagnosis and management are crucial for mitigating long-term complications.
Purpose of the Study:
- To summarize current understanding of JDMS and PM.
- To highlight the importance of prompt medical care for symptomatic children.
- To underscore the need for further research into the epidemiology and genetics of JDMS.
Main Methods:
- Literature review and synthesis of existing data on JDMS and PM.
- Analysis of clinical presentation and therapeutic advancements.
- Discussion of ongoing national research efforts.
Main Results:
- Specific symptoms like rash, proximal muscle weakness, and fatigue warrant immediate medical evaluation in children.
- Current physical and medical therapies can significantly ameliorate disease consequences.
- Preliminary data suggest differing pathophysiologies between JDMS and PM, requiring further investigation.
Conclusions:
- Prompt medical attention is vital for children presenting with JDMS symptoms.
- Therapeutic interventions offer improved prognoses for affected children.
- Further research into the epidemiologic and genetic factors influencing JDMS susceptibility and severity is essential.
Abstract:
In summary, the child who develops the symptoms of the specific rash, proximal muscle weakness, or fatigue should seek medical care promptly. With the advances in physical and medical therapy, many of the consequences of the disease can now be ameliorated. Data suggest that JDMS and PM may each have a different pathophysiology, but more evidence is needed. The next few years will be exciting as there is a national effort by an increased number of investigators to determine the epidemiologic and genetic factors that influence JDMS disease susceptibility and severity.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Myocarditis I: Introduction
Type I Diabetes II: Pathophysiology
Cytotoxic Edema: Pathophysiology
Myasthenia Gravis ll: Pathophysiology

